FDA
approval
· 2022-11-16
FDA Approved: BUPRENORPHINE AND NALOXONE — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
Summary
The FDA approved Sun Pharmaceutical's supplemental application for a generic buprenorphine and naloxone product. This approval expands the availability of this …
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for BUPRENORPHINE AND NALOXONE (BUPRENORPHINE AND NALOXONE)